Fig. 4From: An ex-ante cost-utility analysis of the deemed consent legislation compared to expressed consent for kidney transplantations in Nova ScotiaCost-effectiveness plane for a 1% increase in deceased donor kidney transplantation probability. The cost-effectiveness plane shows the differences in costs and QALYs between the deemed and expressed consent, with the origin depicting the expressed consent. The incremental QALYs (x-axis) represent the differences in expected QALYs between the deemed and the expressed consent. The incremental costs (y-axis) show the differences in expected costs. Each dot in the plane represents one of the 10,000 Monte Carlo simulations from a probabilistic sensitivity analysisBack to article page